Brief: Orexo Q4 EBIT Loss At SEK 103.2 Mln
Feb 5 (Reuters) - Orexo AB ORX.ST: Q4 ADJUSTED EPS SEK -3.33 Q4 EBITDA SEK -70 MILLION Q4 EBIT SEK -103.2 MILLION Q4 EPS SEK -3.33 Q4 REVENUE SEK 3.3 MILLION PROPOSES THAT NO DIVIDEND IS PAID FOR FINANCIAL YEAR 2025 Source text: ID:nMFNbzdRQp Further company coverage: ORX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Orexo AB
See all newsBrief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Pre-Clinical Data For Nasal Atipamezole Using Amorphox Technology
Brief: Orexo AB Reports Q1 2026 Net Revenue Of Sek 5.0 Million
Sweden's Orexo Q1 revenue drops, net loss widens